This directive approach led to a reduction in PONV [ odds ratio ( OR ) : 0.60 , 95 % CI : 0.43-0 .83 ] , with an even greater reduction in PONV in high-risk patients ( OR : 0.45 , 95 % CI : 0.28-0 .72 ) .